|
Dr. Bollon brings 25 years experience in biotechnology as a scientist, executive and entrepreneur. He has been the Chairman, President and CEO of HemoBioTech since 2003.
Founder, former Chairman & CEO of Wadley Biosciences Inc, a joint venture between Wadley Cancer Center and Phillips Petroleum.
Founder, former Chairman & CEO of Cytoclonal Pharmaceutics led an IPO in 1995 and closed licensing agreement with Bristol Meyers Squibb.
Dr. Bollon holds a Ph.D. in molecular genetics from Rutgers University and was a Post Doctoral Fellow at Yale University. | 